CELU
CELU
NASDAQ · Biotechnology

Celularity Inc-A

$1.40
+0.02 (+1.45%)
As of Sep 28, 10:32 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +787.1% upside
Low Target $7.12
Average Target $12.42
High Target $14.14
Current Price $1.40
Current
$1.40
Target
$12.42
$7.12 $12.42 avg $14.14
Scenario Analysis
Bear Case
$7.12
408.6%
Low target
Base Case
$12.42
+787.1%
Avg target
Bull Case
$14.14
+910.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.55
-45.1% from high
52-Week Low
$0.56
+150.0% from low
Target vs 52W High
$12.42
+387.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%